Evidence map›Paper›PMID 30158213›Full record

ArticleDisease models & mechanisms2018

ENPP1 enzyme replacement therapy improves blood pressure and cardiovascular function in a mouse model of generalized arterial calcification of infancy.

Tayeba Khan, Kerstin W Sinkevicius, Sylvia Vong, Arlen Avakian, Markley C Leavitt, Hunter Malanson, Andre Marozsan, Kim L Askew

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Six cases ofJBMR plus · 2025
    Article
  5. Review
  6. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  7. Article
  8. Article
  9. Novel treatment for PXE: Recombinant ENPP1 enzyme therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Weighing the Evidence for the Roles of Plasma Versus Local Pyrophosphate in Ectopic Calcification Disorders.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  15. Article
  16. Review
  17. Review
  18. Rickets guidance: part II-management.Pediatric nephrology (Berlin, Germany) · 2022
    Article
  19. Article
  20. Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tayeba KhanAlexion Pharmaceuticals, Lexington, MA 02421, USA tayeba_khan@yahoo.com.ORCID 0000-0002-7011-5087
Kerstin W SinkeviciusAlexion Pharmaceuticals, Lexington, MA 02421, USA.ORCID 0000-0002-4000-6277
Sylvia VongAlexion Pharmaceuticals, New Haven, CT 06510, USA.
Arlen AvakianAlexion Pharmaceuticals, Lexington, MA 02421, USA.
Markley C LeavittAlexion Pharmaceuticals, Lexington, MA 02421, USA.ORCID 0000-0002-4673-3264
Hunter MalansonAlexion Pharmaceuticals, New Haven, CT 06510, USA.
Andre MarozsanAlexion Pharmaceuticals, New Haven, CT 06510, USA.
Kim L AskewAlexion Pharmaceuticals, Lexington, MA 02421, USA.ORCID 0000-0002-2593-7639
Alexion Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generalized arterial calcification of infancy (GACI) is a rare, life-threatening disorder caused by loss-of-function mutations in the gene encoding ectonucleotide pyrophosphatase phosphodiesterase 1 (

Indexed as

Blood PressureEnzyme Replacement TherapyAnimalsCardiovascular SystemDiphosphatesDisease Models, AnimalHumansMiceMice, Inbred BALB COrgan SpecificityPhosphoric Diester HydrolasesPyrophosphatasesVascular CalcificationDiphosphatesdiphosphoric acidectonucleotide pyrophosphatase phosphodiesterase 1Phosphoric Diester HydrolasesPyrophosphatasesEnpp1Enzyme replacement therapyGACIHypertensionVascular calcification

Identifiers

PMID30158213
PMCPMC6215426
OpenAlexW2889403454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.